Filter By Industry
Filter By Tag
None Found

Newsroom

HillCo HEALTH Press releases

1 - 10 of 10 Press Releases

Nov 21, 2011
HillCo HEALTH Announces Three New Team Members; And an Old Team Member returns.

Nov 22, 2010
HillCo HEALTH's Marc Samuels and Caleb DesRosiers will lead an opening day workshop at CBI's 8th Annual Specialty Pharmaceuticals, Biotech Therapies and Injectables Caesar's Palace, Las Vegas January 26-27, 2011

Nov 12, 2010
HillCo HEALTH CEO Marc Samuels and Alissa Pereira, Director, Healthcare Advisory and Public Policy Practice, join officials from U. T. M. D. Anderson Cancer Center in publishing an article in Cancer, November 8, 2010

Jul 06, 2010
Marc Samuels, CEO of HillCo HEALTH, a reimbursement consulting and strategic business advisory firm to the healthcare industry, will moderate a panel at CBI's 6th Annual Obesity Diabetes Drug Development Summit, July 20-21, 2010, Arlington, Virginia.

Jan 11, 2010
HillCo HEALTH--a Washington DC based strategic B2B and B2G advisory firm--represents a number of lifescience, health, and financial services companies that will be presenting and/or participating at the JP Morgan Healthcare Conference.

Jan 04, 2010
Michael Beebe, HillCo Health Vice President and Former AMA Director/Current Procedural Terminology (CPT®), Participating at Q1 Productions’ Medical Device Clinical Research & Reimbursement Conference, on January 11-12

Jan 04, 2010
HillCo Partners today announced that its Washington, DC office officially changed its name to HillCo Health to reflect its boutique focus and independence from the state lobbying activities of HillCo Partners

Dec 06, 2009
HillCo Health Discusses Role of internet on the Healthcare Reform Debate and U.S. Economy at Google ThinkHealth'09

Nov 29, 2009
HillCo Health, based in Washington DC, is a strategic B2G full-service health policy consulting firm that advises bio-pharmaceutical, medical device, and healthcare companies on federal and state coverage, coding, and payment matters.

Nov 19, 2009
Legislative enacted drug and device reimbursement reforms, and the growing influence of the estimated $1 Trillion government-run healthcare systems, will impact reimbursement for oncology medicines and technologies as well as royalty agreements.


HillCo HEALTH RSS Feed